Purchase Order HHSF223201610468P

The Department of Health and Human Services' National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm-fixed-price purchase order to Protein Technologies Inc. (PTI), a manufacturer of peptide synthesis and bioanalytical technology equipment, to acquire a PurePep Chorus UV-IR peptide synthesizer for $107,107.16. The award provides for onsite installation and a startup kit. The purchase is made using simplified acquisition procedures and...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Peptide 2.0 Inc., doing business as Peptide 20 Inc., for custom peptide synthesis and production services. The award, which did not utilize a small business set-aside, has a potential value of $12,801.20 and a completion date of April 22, 2019. Peptide 2.0 Inc. is a minority-owned, for-profit organization that...

The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,326.00 firm fixed price purchase order to JPT Peptide Technologies GMBH, a foreign-owned, for-profit manufacturer of goods, for custom peptide synthesis. The award, which did not have any set-aside designation, supports research related to cancer, COVID-19, allergies, and infectious diseases. JPT Peptide Technologies has received...

This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to A & A Labs LLC, doing business as Synthetic Biomolecules. The $8,482.00 contract is for the custom synthesis of 15-mer peptides. The contract is set aside for small businesses and the awardee is a minority-owned, self-certified small disadvantaged business. The place of performance is San Diego,...

This federal contract award, valued at $7,575.30, was made by the Food and Drug Administration (FDA) to Anaspec, Inc., a manufacturer of peptides, glycoproteins, and related biochemical products and services. The contract is for services related to custom peptides and was not set aside for any socioeconomic program. Through this and other prime federal contracts, Anaspec has provided various peptides, glycoproteins, antimicrobial peptides, and protein biochemistry services to support research...

This federal contract award is for the CRUDE PEPTIDE SYNTHESIS, with a potential value of $22,593.00. The contract was awarded to A & A Labs LLC, doing business as Synthetic Biomolecules, a minority-owned, self-certified small disadvantaged business, and limited liability company. The contract is a purchase order with a firm fixed price, awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases. The place of...

<p>Genscript USA Inc. has been awarded a $11,395.74 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide purified peptide services. The one-year contract, which runs from July 2023 through July 2024, will support NIH/NIAID's research efforts. No subcontractors or set aside designations were identified. Genscript will perform the peptide purification work at its facility in Piscataway, New Jersey.</p>

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and related research products. The $3,620 firm fixed price purchase order is for the delivery of peptide microarrays displaying peptides from a previous order, in support of NIAID's research activities. The award has no set-aside...

The federal contract award AG7D28P150032 was issued by the Plains Area division of the U.S. Department of Health and Human Services to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and peptide-based products. The $9,758.50 firm fixed price purchase order is for the delivery of PEPSTAR PEPTIDE MICROARRAY PEPTIDES and does not have a set-aside designation. JPT Peptide Technologies has previously received over $250,000 in federal contract awards from...

This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in New Jersey. The $19,530.58 contract requires Genscript to provide 187 custom peptide conjugations at $104.00 each, with an ultimate completion date of October 14, 2010. The contract does not have a set-aside designation. Genscript is a well-established supplier of molecular...